Catatonia: A critical review and therapeutic recommendations

Journal of Psychopathology

Volumn 18, Issue 3, 2012, Pages 234-246

  Bartolommei, N ^a   Lattanzi, Lorenzo ^a   Callari, A ^a   Cosentino, L ^a   Luchini, F ^a   Mauri, M ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Benzodiazepines; Catatonia; Electroconvulsive therapy; Neuroleptic malignant syndrome

Indexed keywords

4 AMINOBUTYRIC ACID; AMANTADINE; ANTICONVULSIVE AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; CLOZAPINE; DIAZEPAM; HEPARIN; LORAZEPAM; LOW MOLECULAR WEIGHT HEPARIN; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; NEUROTRANSMITTER; OLANZAPINE; OXAZEPAM; RISPERIDONE; TOPIRAMATE; VALPROIC ACID; WARFARIN; ZOLPIDEM;

ANTICHOLINERGIC EFFECT; BEHAVIOR DISORDER; CATATONIA; CLINICAL FEATURE; CLINICAL PROTOCOL; COMORBIDITY; DEFENSE MECHANISM; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DOPAMINERGIC ACTIVITY; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; EARLY DIAGNOSIS; ELECTROCONVULSIVE THERAPY; HERITABILITY; HUMAN; MEDICAL LITERATURE; MOTOR DYSFUNCTION; NEUROBIOLOGY; NEUROLEPTIC MALIGNANT SYNDROME; PROGNOSIS; PROVOCATION TEST; REVIEW; SCHIZOPHRENIA; SIDE EFFECT; STUPOR; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE;

EID: 84870873971     PISSN: 15921107     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (142)

1. Kahlbaum K. Die Katatonie oder das Spannungsirresein. Berlin: Hirshwald 1874.
2. nd ed. Leipzig: Barth 1899.
3. Kraepelin E. Dementia Praecox and paraphrenia. Leipzig: Barth 1913.
4. Kraepelin E. Psychiatrie. Ein Lehrbuch fur Studierende und Arzte. Achte, vollstandig umgearbeitete Auflage. 1. Band. Allgemeine Psychiatrie. Leipzig, Germany: Verlag von Johann Ambrosius Barth 1909.
5. Bleuler E. Dementia praecox oder Gruppe der Schizophrenien. In: Aschaffenburg G, editor. Handbuch der Psychiatrie. Spezieller Teil 4. Abteilung 1. Leipzig: Haelfte 1911.
6. Wernicke C. Grundriß der Psychiatrie in klinischen Vorlesungen. Leipzig: Thieme 1900.
7. Kleist K. Die Katatonien. Nervenarzt 1943;16:1-10.
8. Leonhard K. Aufteilung der endogenen Psychosen. Berlin: Akademie Verlag 1957.
9. nd ed. New York: Springer 1999.
10. Stauder KH. Die tödliche Katatonie. Arch Psychiatr Nervenkr 1934;102:614-34.
11. Arnold OH, Stepan H. Untersuchungen zur Frage der akuten tödlichen Katatonie. Wien Z Nervenheilkd Grenzgeb 1952;4:235-58.
12. Billig O, Freeman WT. Fatal catatonia. Am J Psychiatry 1994;100:633-8.
13. Mann SC, Caroff SN, Bleier HR, et al. Lethal catatonia. Am J Psychiatry 1986;143:1374-81. (Pubitemid 17176093)
14. Mann SC, Auriacombe M, Macfadden W, et al. La catatonie lethale: aspects cliniques et thérapeutique. Une revue de la littérature. Encephale 2001;27:213-6. (Pubitemid 32678130)
15. Caroff SN. The neuroleptic malignant syndrome. J Clin Psychiatry 1980;41:79-83. (Pubitemid 10155527)
16. Fricchione G, Mann SC, Caroff SN. Catatonia, lethal catatonia, and neuroleptic malignant syndrome. Psychiatric Annals 2000;30:347-55.
17. American Psychiatric Association Commitee on Nomenclature and Statics. Diagnostic and Statistical Manual: Mental Disorders, Second Edition. Washington, DC: APA 1968.
18. World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death. Sixth Revision. Vol 1. Geneve 1948, p. 106.
19. Morrison JR. Catatonia: diagnosis and treatment. Hosp Community Psychiatry 1975;26:91-4.
20. Taylor MA, Abrams R. The phenomenology of mania: a new look at some old patients. Arch Gen Psychiatry 1973;29:520-2.
21. Taylor MA, Abrams R. Catatonia: prevalence and importance in the manic phase of manic-depressive illness. Arch Gen Psychiatry 1977;34:1223-5. (Pubitemid 8216735)
22. Abrams R, Taylor MA. Catatonia, a prospective clinical study. Arch Gen Psychiatry 1976;33:579-81.
23. Abrams R, Taylor MA, Stolurow KAC. Catatonia and mania: patterns of cerebral dysfunction. Biol Psychiatry 1979;14:111-7. (Pubitemid 9133850)
24. Fink M, Taylor M. Catatonia. A clinician's guide to diagnosis and treatment. Cambridge: University Press 2003.
25. Trivedi H, Mendelowitz A, Fink M. Gilles de la Tourette from of catatonia: response to ECT. J ECT 2003;19:115-7. (Pubitemid 36682534)
26. Sabin TD, Jednacz JA, Staats PN. Case records of the Massachuttes General Hospital: case 26-2008. N Engl J Med 2008;359;842-53.
27. Kakooza-Mwesige A, Watchel LE, Dhossche DM. Catatonia in autism: implications across the life span. Eur Child Adolesc Psychiatry 2008;17:327-35.
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (text Revision). Washington, DC: American Psychiatric Publishing 2000.
29. Taylor M, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003;160:1-9.
30. Fink M, Taylor M. Catatonia subtype or syndrome in DSM? Am J Psychiatry 2006;163:1875-6.
31. Heckers S, Tandon R, Bustillo J. Catatonia in the DSM -Shall we move or not? Schizophr Bull 2010;36:205-7.
32. Morrison JR Catatonia: retarded and excited types. Arch Gen Psychiatry 1973;28:39-41.
33. Abrams R, Taylor MA. Catatonia a prospective clinical study. Arch Gen Psychiatry 1976;33:579-81.
34. Lee JW, Schwartz DL, Hallmayer J, et al. Catatonia in a psychiatric intensive care facility: incidence and response to benzodiazepines. Ann Clin Psychiatry 2000;12:89-96. (Pubitemid 30470154)
35. Francis A, Fink M, Appiani F, et al. Catatonia in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. J ECT 2010;26:246-7.
36. Dhossche DM, Watchel LE. Catatonia in psychiatric illnesses In: Fatemi SH, Clayton PJ, editors. The Medical Basis of Psychiatry. Totowa, NJ: Humana Press 2008.
37. Van der Heijden FM, Tuiner S, Arts NJ, et al. Catatonia: disappeared or under-diagnosed? Psychopatology 2005;38:3-8. (Pubitemid 40529161)
38. Daniels J. Catatonia: clinical aspects and neurobiological correlates J Neuropsychiatry Clin Neurosci 2009;21:371-80.
39. Ungvari GS, Goggins W, Leunk SK, et al. Schizophrenia with prominent catatonic features ("catatonic schizophrenia"). Il Factor analysis of the catatonic syndrome. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:462-8. (Pubitemid 46209443)
40. Barnes MP, Saunders M, Walls TJ, et al. The syndrome of Karl Kahlbaum. J Neurol Neurosurg Psychiatry 1986;49:991-6.
41. Bush G, Fink M, Petrides G, et al. Catatonia I: rating scale and standardized examination. Acta Psychiatr Scand 1996;93:129-36. (Pubitemid 26084530)
42. Rosebush PI, Hildebrand AM, Furlong BG, et al. Catatonic Syndrome in a general psychiatric inpatient population: frequency, clinical presentation and response to lorazepam J Clin Psychiatry 1990;51:357-62. (Pubitemid 20370455)
43. Carroll BT, Goforth HW. Medical catatonia. In: Caroff SN, Mann SC, Francis A, et al., editors. Catatonia from psychopatology to neurobiology. Arlington, VA: American Psychiatric Publishing 2004, p. 123.
44. Dhossche DM, Bouman NH. Catatonia in children and adolescents. J Am Acad Child Adolesc Psychiatry 1997;36:870-1.
45. Dhossche DM. Brief report: catatonia in autistic disorders. J Autism Dev Disord 1998;28:329-31.
46. Wing L, Shah A. Catatonia in autistic spectrum disorders. Br J Psychiatry 2000;176:357-62.
47. Francis A. Catatonia: diagnosis, classification, and treatment. Curr Psychiatry Rep 2010;12:180-5.
48. Scarciglia P, Tarolla E, Biondi M, et al. Valutazione temporale con la Catatonia Rating Scale in un caso di catatonia trattato con diazepam. Riv Psichiatr 2004;39:58-65. (Pubitemid 38314173)
49. Karadenizli D, Dilbar N, Bayam G. Gilles de la Tourette syndrome response to electroconvulsive therapy. J ECT 2005:21:246-8. (Pubitemid 41772229)
50. Elia J, Dell M, Friedman D, et al. PANDAS with catatonia: a case-report. Therapeutic response to lorazepam and plasmapheresis. J Am Acad Child Adolesc Psychiatry 2005;44:1145-50. (Pubitemid 41508126)
51. Baker RA, Revesz T, Thom M, et al. Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndromes, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 1998;65:633-40. (Pubitemid 28486637)
52. Bauer G, Gerstenbrand F, Rumple E. Varieties of the lockedin syndrome. J Neurol 1979;221:77-91.
53. Freudenreich O, Mc Evoy J, Goff D, et al. Catatonic coma with profound bradicardia. Psychosomatics 2007;48:74-8.
54. Bender K, Feutrill J. Comatoid catatonia. Aust N Z J Psychiatry 2000;34:169-70.
55. Arora M, Praharaj SK. Butterfly glioma of corpus callosum presenting as catatonia. World J Biol Psychiatry 2007;8:54-5. (Pubitemid 46291205)
56. Norhoff G, Steinke R, Czcervenka C, et al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry 1999;67:445-50. (Pubitemid 29438198)
57. Northoff G, Ritcher A, Gessner M, et al. Functional dissociation between medial and lateral prefrontal cortical spatiotemporal activation in negative and positive emotions: a combined fMRI/MEG study. Cereb Cortex 2000;10:93-107. (Pubitemid 30022836)
58. Northoff G, Kötter R, Baumgart F, et al. Orbitofrontal cortical dysfunction in akinetic catatonia: a functional magnetic resonance imaging study during negative emotional stimulation. Schizophr Bull 2004;30:405-27. (Pubitemid 38828545)
59. Roberts E. Adventures with GABA. Fifty years on In: Martin D, Olsen R, editors. GABA in the in the Nervous System. The view at fifty years. Philadelphia, PA: Lippincott Williams & Wilkins 2000, pp. 1-24.
60. Northoff G, Eckert J, Fritze J, et al. Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonia patients with NMDA antagonist amantidine. J Neurol Neurosurg Psychiatry 1997;62:404-6. (Pubitemid 27199118)
61. Carroll BT, Goforth HW, Thomas C, et al. Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes. J Neuropsychiatry Clin Neurosci 2007;19:406-12. (Pubitemid 350156098)
62. Northoff G. What catatonia can tell about "top-down modulation": a neuropsychiatric hypothesis. Behav Brain Sci 2002;25:555-77, discussion 578-604.
63. Gjessing R. A review of periodic catatonia. Biol Psychiatry 1974;8:23-45.
64. Nisijima K, Ishiguro T. Cerobrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndrome. J Psychiatr Res 1995;29:233-44.
65. Norhoff G, Demisch L. Wenke J, et al. Plasma homovanillic acid concentration in catatonia. Biol Psychiatry 1996;39:436-43.
66. Carroll BT. The universal field hypothesis of catatonia and neuroleptic malignant syndrome. CNS Spectr 2000;5:26-33. (Pubitemid 30620049)
67. Northoff G, Steinke R, Nagel D, et al. Right lower prefronto-parietal cortical dysfunction in akinetic catatonia: a combined study of neuropsychology and regional cerebral blood flow. Psychol Med 2000;30:583-96. (Pubitemid 30410322)
68. Northoff G, Krill W, Eckert J, et al. Subjective experience of akinesia in catatonia and Parkinson's disease. Cogn Neuropsychiatry 1998;3:161-78.
69. Northoff G. Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology. J Neural Transm 2002;109:1453-67. (Pubitemid 36061257)
70. Beckmann H, Franzek E, Stiber G, et al. Genetic heterogeneity in catatonic schizophrenia: a family study. Am J Med Genet 1996;67:289-300.
71. Stober G, Saar K, Ruschendorf F, et al. Splitting schizophrenia periodic catatonia susceptibility locus on chromosome 15q15. Am J Hum Genet 2000;8:213-9.
72. Stober G, Seelow D, Ruschendorf F, et al. Periodic catatonia: confirmation of linkage to chromosome 15 and further evidence for genetic heterogeneity. Hum Genet 2002;111:323-30. (Pubitemid 36075058)
73. Dhossche D, Bouman N. Catatonia in an adolescent with Prader-Willi syndrome. Ann Clin Psychiatry 1997;4:247-53. (Pubitemid 28122130)
74. Clarke D. Prader-Willi syndrome and psychoses. Br J Psychiatry 1993;163:680-4.
75. Abe K, Otha M. Recurrent brief episodes with psychotic features in adolescence: periodic psychosis of puberty revisited. Br J Psychiatry 1995;167:507-13. (Pubitemid 26194154)
76. Bartolucci G, Younger J. Tentative classification of neuropsychiatric disturbances in Prader-Willi syndrome. J Intellect Disab Res 1994;167:621-9.
77. Verhoeven W, Tuinier S. Prader-Willi syndrome: atypical psychoses and motor disfunctions. Int Rev Neurobiol 2006;72:119-30. (Pubitemid 43660086)
78. Verhoeven W, Curfs L, Tuinier S. Prader-Willi syndrome and cycloid psychoses. Intellect Disabil Res 1998;42:445-62.
79. Boer H, Holland A, et al. Psychotic illness in people with Prader-Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet 2002;12:135-6. (Pubitemid 34112546)
80. Vogels A, Matthijs G, Legius E, et al. Chromosome 15 maternal uniparental disomy and psychosis in Prader-Willi syndrome. J Med Genet 2003;40:72-3. (Pubitemid 36115130)
81. Cook E, Courchesne R, Cox N, et al. Linkage-disequilibrium mapping of autistic disorders with 15q11-13 markers. Am J Hum Genet 1998;62:1077-83. (Pubitemid 28199008)
82. Chagnon Y. Shared susceptibility region on chromosome 15 between autism and catatonia. Int Rev Neurobiol 2006;72:165-78. (Pubitemid 43660071)
83. Carroll BT. Catatonia on the consultation-liaison service. Psychosomatics 1992;33:310-5.
84. McCall WV, Mann SC, Shelp FE, et al. Fatal pulmonary embolism in the catatonic syndrome: two case reports and a literature review. J Clin Psychiatry 1995;56:21-5.
85. Swartz C, Galang RL. Adverse outcome with delay in identification of catatonia in elderly patients. Am J Geriatr Psychiatry 2001;9:78-80. (Pubitemid 32062076)
86. Lachner C, Sandson NB. Medical complications of catatonia: a case of catatonia-induced deep venous thrombosis. Psychosomatics 2003;44:512-4. (Pubitemid 37352230)
87. Srivastava A, Gupta A, Murthy P, et al. Catatonia and multiple pressure ulcers: a rare complication in psychiatric setting. Indian J Psychiatry 2009;51:206-8.
88. Bush G, Fink M, Petrides G, et al. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand. 1996;93:137-43. (Pubitemid 26084531)
89. Rosebush P, Mazurek M. Pharmacotherapy. In: Caroff SN, Mann SC, Francis A, et al., editors. Catatonia: From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Press 2004, pp. 141-50.
90. Hawkins JM, Archer KJ, Strakowski SM, et al. Somatic treatment of catatonia. Int J Psychiatry Med 1995;25:345-69. (Pubitemid 26030461)
91. Zisselman MH, Jaffe RL. ECT in the treatment of a patient with catatonia: consent and complications. Am J Psychiatry 2010;167:127-32.
92. Grisaru N, Chudakov B, Yaroslavsky Y, et al. Catatonia treated with transcranial magnetic stimulation. Am J Psychiatry 1998;155:1626.
93. Saba G, Rocamora JF, Kalalou K, et al. Catatonia and transcranial magnetic stimulation. Am J Psychiatry 2002;159:1794.
94. Vittorio DM, Bolino F. A novel treatment option of bipolar depression with psychotic and catatonic features. Gen Hosp Psychiatry 2006;28:364-5. (Pubitemid 43929139)
95. Carpenter S, Hatchett AD, Fuller MA. Catatonic schizophrenia and the use of memantine. Ann Pharmacother 2006;40:344-6. (Pubitemid 43269871)
96. Munoz C, Yulan N, Achaval V, et al. Memantine in major depression with catatonic features. J Neuropsychiatry Clin Neurosci 2008;20:119-20. (Pubitemid 351295051)
97. Thomas P, Rascle C, Mastain B, et al. Test for catatonia with zolpidem. Lancet 1997;349:702-5.
98. Thomas P, Cottencin O, Rascle C, et al. Implications of the zolpidem challenge test. Psychiatr Ann 2007;37:45-54.
99. Yoshida I, Monji A, Hashioka S, et al. Prophylactic effect of valproate in the treatment for siblings with catatonia: a case report. J Clin Psychopharmacology 2005;5:504.
100. McDaniel WW, Spiegel DR, Sahota AK. Topiramate effect in catatonia: a case series. J Neuropsychiatry Clin Neurosci 2006;18:234-7.
101. Valevski A, Loebl T, Karen T, et al. Response of catatonia to risperidone: two case reports. Clin Neuropharmacology 2001;24:228-31. (Pubitemid 32717857)
102. Numata S, Kato O, Misawa H, et al. Treatment of catatonia with olanzapine. Ger J Psychiatr 2002;5:115-6. (Pubitemid 37207267)
103. Van Den Eede F, Van Hecke J, Van Dalfsen A, et al. The use of atypical antipsychotics in the treatment of catatonia. Eur Psychiatry 2005;20:422-9. (Pubitemid 41318009)
104. Hung YY, Yang PS, Huang TL. Clozapine in schizophrenia patients with recurrent catatonia: report of two cases. Psychiatry Clin Neurosci 2006;60:256-8.
105. Bahro M, Kampf C, Strnad J. Catatonia under medication with risperidone in a 61-year-old patient. Acta Psychiatr Scand 1999;99:223-4.
106. Markham-Abedi C, McNeely C, DeLeon J. A case report with ziprasidone-induced catatonic symptoms. J Neuropsychiatry. Clin Neurosci 2007;19:476.
107. Hanft A, Eggleston CF, Bourgeois JA. Neuroleptic malignant syndrome in an adolescent after brief exposure to olanzapine. J Child Adolesc Psychopharmacol 2004;14:481-7. (Pubitemid 39473136)
108. Croarkin PE, Emslie GJ, Mayes TL. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases. J Clin Psychiatry 2008;17:e1-9.
109. Ladds B, Thomas P, Mejia C, et al. Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypicalantipsychotics. Am J Psychiatry 2009;166:114-5.
110. El-Gaaly S, St John P, Dunsmore S, Bolton JM. Atypical neuroleptic malignant syndrome with quetiapine: a case report and review of the literature. J Clin Psychopharmacol 2009;29:497-9.
111. Trollor JN, Chen X, Sachdev PS. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs 2009;23:477-92.
112. Ungvari GS, Leung CM, Wong MK, et al. Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatr Scand 1994;89:285-8. (Pubitemid 24134691)
113. Huang TL. Lorazepam and diazepam rapidly relieve catatonic signs in patients with schizophrenia. Psychiatry Clin Neurosci 2005;59:52-5.
114. Schmider J, Standhart H, Deuschle M, et al. A double-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutism. Biol Psychiatry 1999;46:437-741.
115. Benazzi F. Parenteral clonazepam for catatonia. Can J Psychiatry 1991;36:312.
116. Lee JW, Schwartz DL, Hallmayer J. Catatonia in a psychiatric intensive care facility: incidence and response to benzodiazepines. Ann Clin Psychiatry 2000;12:89-96. (Pubitemid 30470154)
117. Kumar R. Acute severe catatonia in a young woman with chronic schizophrenia responding to parenteral clonazepam. Aust N Z J Psychiatry 2001;35:391.
118. Clothier JL, Pazzaglia P, Freeman TW. Evaluation and treatment of catatonia. Am J Psychiatry 1989;146:553-4.
119. McEvoy JP. Relief from catatonic immobility can be maintained. J Clin Psychopharm 1986;6:126-7.
120. Ungvari GS, Chiu HFK, Chow LY, et al. Lorazepam for chronic catatonia: a randomized double-blind, placebo controlled cross-over study. Psychopharmacology 1999;142:393-8. (Pubitemid 29187628)
121. Petrides G, Divadeenam K, Bush G, et al. Synergism of lorazepam and ECT in the treatment of catatonia. Biol Psychiatry 1997;42:375-81. (Pubitemid 27380972)
122. nd ed. Washington, DC: American Psychiatric Association 2001.
123. Caroff SN, Ungvari GS, Bhati MT, et al. Catatonia and prediction of response to electroconvulsive therapy. Psychiatr Ann 2007;37:57-64.
124. Manjunatha N, Saddichha S, Khess CR. Idiopathic recurrent catatonia needs maintenance lorazepam: case report and review. Aust N Z J Psychiatry 2007;41:625-7. (Pubitemid 46930101)
125. Bhati MT, Datto CJ, O'Reardon JP. Clinical manifestations, diagnosis, and empirical treatments for catatonia. Psychiatry (Edgmont) 2007;4:46-52.
126. van Waarde JA, Tuerlings JH, Verwey B, et al. Electroconvulsive therapy for catatonia: treatment characteristics and outcomes in 27 patients. J ECT 2010;26:248-52.
127. Nobler MS, Sackeim HA. Neurobiological correlates of the cognitive side effects of electroconvulsive therapy. J ECT 2008;24:40-5. (Pubitemid 351498641)
128. Ingram A, Saling MM, Schweitzer I, et al. Cognitive side effects of brief pulse electroconvulsive therapy: a review. J ECT 2008;24:3-9. (Pubitemid 351498635)
129. Sackeim HA, Prudic J, Fuller R, et al. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology 2007;32:244-54. (Pubitemid 44967804)
130. Vamos M. The cognitive side effects of modern ECT: patient experience or objective measurement? J ECT 2008;24:18-24. (Pubitemid 351498637)
131. Brakemeier EL, Berman R, Prudic J, et al. Self-evaluation of the cognitive effects of electroconvulsive therapy. J ECT 2011;27:59-66.
132. Malur C, Francis A. Emergence of catatonia during ECT. J ECT 2001;17:201-4. (Pubitemid 32831378)
133. Ahuja N, Carroll BT. Possible anti-catatonic effects of minocycline in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:968-9. (Pubitemid 46671479)
134. Hudcova J, Schumann R. Electroconvulsive therapy complicated by life-threatening hyperkalemia in a catatonic patient. Gen Hosp Psychiatry 2005;28:440-2.
135. Matthew JR, Constan E. Complications following ECT over a three-year period in a state institution. Am J Psychiatry 1964;120:1119-20.
136. Mamah D, Lammle M, Isenberg KE. Pulmonary embolism after ECT. J ECT 2005;21:39-40. (Pubitemid 40476143)
137. Singh G, Wahi S. Pulmonary embolism in the ECT patient: a case report and discussion. Gen Hosp Psychiatry 2008;30:87-9. (Pubitemid 350299499)
138. Mehta V, Mueller PS, Gonzalez-et al. Safety of electroconvulsive therapy in patients receiving long-term warfarin therapy. Mayo Clin Proc 2004;79:1396-401. (Pubitemid 39453304)
139. Suzuki K, Takamatsu K, Takano T, et al. Safety of electroconvulsive therapy in psychiatric patients shortly after the occurrence of pulmonary embolism. J ECT 2008;24:286-8.
140. Gorforth H. Amantadine in catatonia due to major depressive disorder in a medically ill patient. J Neuropsychiatry Clin Neurosci 2007;19:480-1.
141. Cassidy EM, O'Brien M, Osman MF, et al. Lethal catatonia responding to high-dose olanzapine therapy. J Psychopharmacology 2001;15:302-4. (Pubitemid 34024250)
142. Carroll BT, Lee JW. Catatonia is a risk factor for neuroleptic malignant syndrome. J Clin Psychiatry 2004;65:1722-3.